Externally-used medicine for treating myositis ossificans

A technology for myositis ossificans and topical drugs, applied in drug combinations, medical preparations containing active ingredients, bone diseases, etc., can solve the problems of exacerbating traumatic myositis ossificans and achieve the effect of reducing ALP levels

Inactive Publication Date: 2015-10-14
程明国
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This new compound can be found naturally or artificially produced for use in treating muscle injuries caused by repetitive strains during exercise activities. It works differently than existing medications due to its unique properties - they work better when applied externally compared to other methods.

Problems solved by technology

This patented technical problem addressed in this patents relates to treating muscle tissue affected by vasculopathies such as hemangiomas called spongiform necrosis syndrome because these symptoms may include painful inflammatory processes like arthritis and perforated sclerosis. Traditional therapists usually take care during medical procedures due to their lack of effective tools for achieving complete removal without causing complications.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1, the weight ratio of raw materials: Lushuicao 20g, Pearl Rhizoma 6g, Selaginella selaginella 12g, Stinky Indus 15g, Azalea 15g, Hercynida 15g, Pailouqi 15g, Rhizoma 15g, Polygonatum 15g, Tortoise shell 12g , Laojunxu 2g, willow moss 2g.

Embodiment 2

[0029] Example 2, the weight ratio of raw materials: 10 parts of Lushuicao, 3 parts of Pearl Rhizoma, 3 parts of Selaginella creeping, 12 parts of Stinky Indus, 12 parts of Osmanthus parsley, 12 parts of Haissian, 12 parts of Pailou Qi, and Miangen vine 12 parts, 12 parts of sealwort, 3 parts of tortoise shell, 1 part of Laojun's beard, 1 part of willow leaf moss.

[0030] The preparation method of Examples 1-2 is: mix Lushuicao, Haisui, Pearl Fengzi, Polygonatum, Selaginella climbing, Stinky Indus, Osmanthus parsley, Pailouqi, Miangen vine, Laojunxu, tortoise shell, and willow moss Add water to decoct for 2 times, each time for 1 hour, filter, concentrate the filtrate to a relative density of 1.38-1.40 (50°C) to obtain a clear paste, and spray dry the clear paste to obtain a dry paste.

Embodiment 3

[0031] Example 3, the weight ratio of raw materials: 20 parts of Lushuicao, 8 parts of Pearl Rhizoma, 12 parts of Selaginella climbing, 15 parts of Stinky Indus, 15 parts of Osmanthus chinensis, 15 parts of Sea Scythe, 15 parts of Pailou Qi, and Miangen vine 15 parts, sealwort 15 parts, tortoise shell 12 parts, Laojunxu 2 parts, willow leaf moss 2 parts.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an externally-used medicine for treating myositis ossificans. The problems in treatment of the myositis ossificans are solved through the externally-used medicine. The externally-used medicine is characterized by being prepared by a common cyanotis root, timonius arboreus, bodinier beauty-berry seeds, sealwort, selaginella davidii, harlequin glorybower leaves, sium latifolium, cypripedium franchetii wils., a ivy glorybind herb root, cynanchum mooreanum, tortoise shells and amblystegium serpens. Clinical experiments show that the externally-used medicine has the beneficial effects of being good in curative effect and higher in safety when being used for treating the myositis ossificans; and the externally-used medicine is worthy of clinical application and popularization.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 程明国
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap